STADA: Supervisory Board elects Carl Ferdinand Oetker as new Chairman of the Board

27/08/2016


STADA: Supervisory Board elects Carl Ferdinand Oetker as new Chairman of the Board

Bad Vilbel, August 27, 2016 –

The Supervisory Board of STADA Arzneimittel AG has elected Carl Ferdinand Oetker as new Chairman of the Board today. Prior to this the Annual General Meeting has removed former Chairman Dr. Martin Abend (see also previous Ad-hoc-release of August 26, 2016). In addition to the four newly elected Supervisory Board Members Dr. Birgit Kudlek, Tina Müller, Dr. Gunnar Riemann, and Rolf Hoffmann the Annual General Meeting has also elected Eric Cornut as a further member of the Supervisory Board.
 
Additional information for analysts:
STADA Arzneimittel AG / Investor Relations / Stadastraße 2–18 / 61118 Bad Vilbel – Germany /
Tel.: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-215 / E-mail: ir@stada.de


Additional information for journalists:
STADA Arzneimittel AG / Media Relations / Stadastraße 2–18 / 61118 Bad Vilbel – Germany /
Tel.: +49 (0) 6101 603-165 / Fax: +49 (0) 6101 603-215 / E-mail: press@stada.de

Download in PDF format

Share:

Related Posts

STADA Arzneimittel AG: Supervisory Board of STADA Arzneimittel AG appoints Peter Goldschmidt as new Chairman of the Executive Board as of September 1, 2018
The Supervisory Board of STADA Arzneimittel AG appointed Peter Goldschmidt today as new Chairman of the Executive Board as of September 1, 2018.
STADA: Successfully concluded purchase of the Russian branded product portfolio Aqualor® for the self-medication of sinusitis and sore throat
STADA: Successfully concluded purchase of the Russian branded product portfolio Aqualor® for the self-medication of sinusitis and sore throat
STADA: Significant renewal of Supervisory Board brought forward by two years – Annual General Meeting 2016 postponed to August 26, 2016
STADA: Significant renewal of Supervisory Board brought forward by two years – Annual General Meeting 2016 postponed to August 26, 2016